Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV467
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,438
Award facts
- Contract value 100% obligated
- $48,438.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $48.4K to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injections on January 12, 2026, with completion scheduled for January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order execution under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9M global pharmaceutical support vehicle valued through December 2026 that enables the distributor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, operating as a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal healthcare vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company serves essential medical procurement needs for military and veteran healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare institutions. This particular delivery order for Zepbound, a diabetes medication, exemplifies the company's broad portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain and reflects its capability to fulfill federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26FV467?
SPE2DR26FV467 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV467 worth?
The government has obligated $48,438 on SPE2DR26FV467.
Is contract SPE2DR26FV467 an order under another contract?
Yes. SPE2DR26FV467 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV467 competed?
The extent of competition for SPE2DR26FV467 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award